CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Short Term Loans and Advances | ₹1.64 Cr | ₹1.63 Cr | ₹7.44 Cr | ₹1.21 Cr |
What is the latest Short Term Loans and Advances ratio of CONCORD DRUGS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1.64 Cr |
| Mar2024 | ₹1.63 Cr |
| Mar2023 | ₹7.44 Cr |
| Mar2022 | ₹1.21 Cr |
How is Short Term Loans and Advances of CONCORD DRUGS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.64 Cr | 0.86 | |
| Mar2024 | ₹1.63 Cr | -78.08 | |
| Mar2023 | ₹7.44 Cr | 514.46 | |
| Mar2022 | ₹1.21 Cr | - | |
Compare Short Term Loans and Advances of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹94.2 Cr | -1.5% | -11.7% | 5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -1.5% |
-11.7% |
5.5% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses